Guillain–Barré syndrome in Colombia: where do we stand now?
Guillain–Barré syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) inf...
Autores Principales: | , , , , |
---|---|
Formato: | Artículo (Article) |
Lenguaje: | Inglés (English) |
Publicado: |
Humana Press Inc.
2017
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/24280 https://doi.org/10.1007/s12026-016-8816-8 |
id |
ir-10336-24280 |
---|---|
recordtype |
dspace |
spelling |
ir-10336-242802022-05-02T12:37:13Z Guillain–Barré syndrome in Colombia: where do we stand now? Mahecha, María P. Ojeda, Ernesto Vega, Daniel A. Sarmiento-Monroy, Juan C. Anaya, Juan-Manuel Corticosteroid Corticotropin Immunoglobulin Prednisone Acute inflammatory demyelinating polyneuropathy Acute motor axonal neuropathy Article Autoimmune disease Colombia Deep vein thrombosis Drug megadose Dysautonomia Electromyography Gastrointestinal infection Graves disease Guillain barre syndrome Human Incidence Intervention study Literature Lung embolism Meta analysis Muscle strength Muscle weakness Nerve conduction Outcome assessment Peripheral nervous system Plasmapheresis Priority journal Systematic review Urinary tract infection Vaccination Ventilator associated pneumonia Zika virus Colombia Guillain barre syndrome Immunology Pathophysiology Colombia Guillain-barre syndrome Humans Anti-gangliosides antibodies Guillain–barré syndrome Latin america Zika virus Guillain–Barré syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) infection, we aimed to assess the available evidence of the disease in Colombia through a systematic literature review. Out of 51 screened abstracts, only 16 corresponded to articles that met inclusion criteria, of which 15 were case reports or case series. A total of 796 cases of GBS were reported in the included articles. The majority of patients were males (66.8 %) and younger than 50 years old (94 %). An infectious disease before the onset of GBS was registered in 31 % of patients, with gastrointestinal or respiratory symptoms being the most frequently observed. In those cases in which electrodiagnostic tests were performed, the most common subphenotype was acute inflammatory demyelinating polyneuropathy (17 %). Death was reported in 15 % of patients. Data regarding GBS in Colombia is scant and heterogeneous. Taking into account the burden of the disease and the recent rise of GBS cases associated with ZIKV, a careful patient evaluation and a systematic collection of data are warranted. A form to data gathering is proposed. © 2016, Springer Science+Business Media New York. 2017 2020-05-26T00:11:05Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 0257277X https://repository.urosario.edu.co/handle/10336/24280 https://doi.org/10.1007/s12026-016-8816-8 eng info:eu-repo/semantics/openAccess application/pdf Humana Press Inc. instname:Universidad del Rosario |
institution |
EdocUR - Universidad del Rosario |
collection |
DSpace |
language |
Inglés (English) |
topic |
Corticosteroid Corticotropin Immunoglobulin Prednisone Acute inflammatory demyelinating polyneuropathy Acute motor axonal neuropathy Article Autoimmune disease Colombia Deep vein thrombosis Drug megadose Dysautonomia Electromyography Gastrointestinal infection Graves disease Guillain barre syndrome Human Incidence Intervention study Literature Lung embolism Meta analysis Muscle strength Muscle weakness Nerve conduction Outcome assessment Peripheral nervous system Plasmapheresis Priority journal Systematic review Urinary tract infection Vaccination Ventilator associated pneumonia Zika virus Colombia Guillain barre syndrome Immunology Pathophysiology Colombia Guillain-barre syndrome Humans Anti-gangliosides antibodies Guillain–barré syndrome Latin america Zika virus |
spellingShingle |
Corticosteroid Corticotropin Immunoglobulin Prednisone Acute inflammatory demyelinating polyneuropathy Acute motor axonal neuropathy Article Autoimmune disease Colombia Deep vein thrombosis Drug megadose Dysautonomia Electromyography Gastrointestinal infection Graves disease Guillain barre syndrome Human Incidence Intervention study Literature Lung embolism Meta analysis Muscle strength Muscle weakness Nerve conduction Outcome assessment Peripheral nervous system Plasmapheresis Priority journal Systematic review Urinary tract infection Vaccination Ventilator associated pneumonia Zika virus Colombia Guillain barre syndrome Immunology Pathophysiology Colombia Guillain-barre syndrome Humans Anti-gangliosides antibodies Guillain–barré syndrome Latin america Zika virus Mahecha, María P. Ojeda, Ernesto Vega, Daniel A. Sarmiento-Monroy, Juan C. Anaya, Juan-Manuel Guillain–Barré syndrome in Colombia: where do we stand now? |
description |
Guillain–Barré syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) infection, we aimed to assess the available evidence of the disease in Colombia through a systematic literature review. Out of 51 screened abstracts, only 16 corresponded to articles that met inclusion criteria, of which 15 were case reports or case series. A total of 796 cases of GBS were reported in the included articles. The majority of patients were males (66.8 %) and younger than 50 years old (94 %). An infectious disease before the onset of GBS was registered in 31 % of patients, with gastrointestinal or respiratory symptoms being the most frequently observed. In those cases in which electrodiagnostic tests were performed, the most common subphenotype was acute inflammatory demyelinating polyneuropathy (17 %). Death was reported in 15 % of patients. Data regarding GBS in Colombia is scant and heterogeneous. Taking into account the burden of the disease and the recent rise of GBS cases associated with ZIKV, a careful patient evaluation and a systematic collection of data are warranted. A form to data gathering is proposed. © 2016, Springer Science+Business Media New York. |
format |
Artículo (Article) |
author |
Mahecha, María P. Ojeda, Ernesto Vega, Daniel A. Sarmiento-Monroy, Juan C. Anaya, Juan-Manuel |
author_facet |
Mahecha, María P. Ojeda, Ernesto Vega, Daniel A. Sarmiento-Monroy, Juan C. Anaya, Juan-Manuel |
author_sort |
Mahecha, María P. |
title |
Guillain–Barré syndrome in Colombia: where do we stand now? |
title_short |
Guillain–Barré syndrome in Colombia: where do we stand now? |
title_full |
Guillain–Barré syndrome in Colombia: where do we stand now? |
title_fullStr |
Guillain–Barré syndrome in Colombia: where do we stand now? |
title_full_unstemmed |
Guillain–Barré syndrome in Colombia: where do we stand now? |
title_sort |
guillain–barré syndrome in colombia: where do we stand now? |
publisher |
Humana Press Inc. |
publishDate |
2017 |
url |
https://repository.urosario.edu.co/handle/10336/24280 https://doi.org/10.1007/s12026-016-8816-8 |
_version_ |
1740172851864928256 |
score |
12,131701 |